Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-protein vaccine is effective against COVID-19: Phase 3, randomized, double-blind, placebo-controlled clinical trial.
Rabdano SO, Ruzanova EA, Vertyachikh AE, Teplykh VA, Emelyanova AB, Rudakov GO, Arakelov SA, Pletyukhina IV, Saveliev NS, Lukovenko AA, Fakhretdinova LN, Safi AS, Zhirenkina EN, Polyakova IN, Belozerova NS, Klykov VV, Savelieva AP, Ekimov AA, Pokachalov KV, Merkulov VA, Yudin SM, Kruchko DS, Berzin IA, Skvortsova VI; Clinical Trial Group. Rabdano SO, et al. Among authors: vertyachikh ae. J Infect. 2024 Nov;89(5):106288. doi: 10.1016/j.jinf.2024.106288. Epub 2024 Sep 26. J Infect. 2024. PMID: 39341405 Free article. Clinical Trial.
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine.
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G, Pletyukhina I, Saveliev N, Zakharov K, Alpenidze D, Vasilyuk V, Arakelov S, Skvortsova V. Rabdano S, et al. Vaccines (Basel). 2024 Jan 19;12(1):100. doi: 10.3390/vaccines12010100. Vaccines (Basel). 2024. PMID: 38276672 Free PMC article.